CMMBVSCTSO• 28 Days (Normalized)
CMMB vs CTSO (Chemomab Therapeutics Ltd. vs Cytosorbents Corporation)
Showing Closing Date Range from Sep 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-38.83%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
CTSO Performance $4.91
+%
Cytosorbents Corporation
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
-38.83 pts
CTSO outperforming by 38.83 percentage points
CMMBCTSO
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB CTSO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | CMMB Price | CMMB Gain (%) | CTSO Price | CTSO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -38.83% | $- | - | |
| Sep 28, 2026 | $1.64 | -39.93% | $- | - | |
| Sep 25, 2026 | $2.16 | -20.88% | $- | - | |
| Sep 24, 2026 | $2.20 | -19.41% | $- | - | |
| Sep 23, 2026 | $2.28 | -16.48% | $4.91 | +1352.66% | -1369.14% |
| Sep 22, 2026 | $2.51 | -8.06% | $- | - | |
| Sep 21, 2026 | $2.48 | -9.16% | $5.51 | +1530.18% | -1539.34% |
| Sep 18, 2026 | $2.61 | -4.40% | $5.75 | +1601.18% | -1605.58% |
| Sep 17, 2026 | $2.80 | +2.56% | $5.76 | +1604.14% | -1601.58% |
| Sep 16, 2026 | $2.65 | -2.93% | $5.73 | +1595.27% | -1598.20% |
| Sep 15, 2026 | $2.47 | -9.52% | $6.06 | +1692.90% | -1702.42% |
| Sep 14, 2026 | $2.45 | -10.26% | $6.07 | +1695.86% | -1706.12% |
| Sep 11, 2026 | $2.58 | -5.49% | $6.41 | +1796.45% | -1801.94% |
| Sep 10, 2026 | $2.60 | -4.76% | $6.37 | +1784.62% | -1789.38% |
| Sep 09, 2026 | $2.69 | -1.47% | $6.33 | +1772.78% | -1774.25% |
Page 1 of 2